Progesterone blunts vascular endothelial cell secretion of endothelin-1 in response to placental ischemia

American Journal of Obstetrics and Gynecology

Volumn 209, Issue 1, 2013, Pages 44.e1-44.e6

  Kiprono, Luissa V ^a   Wallace, Kedra ^b   Moseley, Janae ^b   Martin Jr , James ^a   LaMarca, Babbette ^b  

^a UNIVERSITY OF MISSISSIPPI   (United States)

^b UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

Endothelin; Placental ischemia; Preeclampsia; Progesterone

Indexed keywords

ENDOTHELIN 1; INTERLEUKIN 17; INTERLEUKIN 6; PROGESTERONE; VASCULOTROPIN RECEPTOR;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CESAREAN SECTION; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEALTH CARE QUALITY; HUMAN; HUMAN CELL; LITTER SIZE; MATERNAL AGE; MEAN ARTERIAL PRESSURE; MORTALITY; NONHUMAN; PERINATAL MORBIDITY; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; PROTEIN SECRETION; RAT; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84880136251     PISSN: 00029378     EISSN: 10976868     Source Type: Journal    
DOI: 10.1016/j.ajog.2013.03.032     Document Type: Article

References (25)

1. Chappell L, Enyse S, Seed P, Briley A, Poston L, Shennan A. Adverse perinatal outcomes and risk factors for preeclampsia in women with chronic hypertension: A prospective study. Hypertension 2008;51: 1002-9. (Pubitemid 351398985)
2. Davey D, Macgilivray I, James M, Richard J. Classification of hypertensive disorders in pregnancy. Lancet 1989;334:112-3.
3. Roberts J, Pearson G, Cutler J, Lindheimer M. Summary of the NHLBI working group on research on hypertension during pregnancy. Hypertension 2003;41:437-45. (Pubitemid 36314613)
4. Laresgoiti-Servitje E, Gomez-Lopez N. The pathophysiology of preeclampsia involves altered levels of angiogenic factors promoted by hypoxia and autoantibodyemediated mechanisms. Biology of Reproduction 2012; 87:36. Available at: Http://dx.doi.org/10.1095/biolreprod.112.099861. Accessed April 25, 2013.
5. Conrad K, Benyo D. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Immunol 1997;37:240-9. (Pubitemid 27149786)
6. LaMarca B, Bennett W, Alexander B, Cockrell K, Granger J. Hypertension produced by reductions in uterine perfusion in the pregnant rat: Role of tumor necrosis factor-alpha. Hypertension 2005;46:1022-5.
7. Alexander B, Rinewalt A, Cockrell K, Massey M, Bennett W, Granger J. Endothelin type A receptor blockade attenuates the hypertension in response to chronic reductions in uterine perfusion pressure. Hypertension 2001; 37:485-9. (Pubitemid 32199016)
8. Roberts L, LaMarca B, Fournier L, Bain J, Cockrell K, Granger J. Enhanced endothelin synthesis by endothelial cells exposed to sera from pregnant rats with decreased uterine perfusion. Hypertension 2006;47: 615-8. (Pubitemid 43843885)
9. Sfakianaki A, Norwitz E. Mechanisms of progesterone action in inhibiting prematurity. J Matern Fetal Neonatal Med 2006;19:763-72. (Pubitemid 46039641)
10. Saghafi N, Khadem N, Mohajeri T, Shakeri M. Efficacy of 17-alpha-hydroxyprogesterone caproate in prevention of preterm delivery. J Obstet Gynaecol Res 2011;37: 1342-5.
11. Merlob P, Stahl B, Klinger G. 17-alpha-Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth. Reprod Toxicol 2012;33:15-9.
12. Society for Maternal-Fetal Medicine Publications Committee; Berghella V. Progesterone and preterm birth prevention: Translating clinical trials data into clinical practice. Am J Obstet Gynecol 2012;5:376-86.
13. Luo G, Abrahams V, Tadesse S, et al. Progesterone inhibits basal and TNF-alpha-induced apoptosis in fetal membranes: A novel mechanisms to explain progesterone-mediated prevention of preterm birth. Reprod Sci 2010;17: 532-9.
14. Mehrer S, Duley L. Progesterone for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2006;4: CD006175.
15. Sammour MB, El-Kabarity H, Khalifa AS. Progesterone therapy in pre-eclamptic toxaemia. Acta Obstet Gynecol Scand 1975;54: 195-202.
16. Granger J, Alexander B, Llinas M, Bennett W, Khalil R. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 2001;38:718-22.
17. BenyoD, Smarason A, RedmanC, Sims C, Conrad K. Expression of inflammatory cytokines in placentas from women with preeclampsia. J Clin Endocrinol Metab 2001;86: 2502-12.
18. Keiser S, Veillon E, Parrish M, et al. Effects of 17-hydroxyprogesterone on tumor necrosis factor-alpha-induced hypertension during pregnancy. Am J Hypertens 2009;22:1120-5.
19. Veillon E, Keiser S, Parrish M, et al. 17-Hydroxyprogesterone blunts the hypertensive response associated with reductions in uterine perfusion pressure in pregnant rats. Am J Obstet Gynecol 2009;201:324. e1-6.
20. Terrone D, Rinehart B, May W, Martin R, Martin JJ. The myth of transient hypertension: Descriptor or disease process? Am J Perinatol 2001;18:73-7. (Pubitemid 32487884)
21. LaMarca B, Cockrell K, Sullivan E, Bennett W, Granger J. Role of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant rats. Hypertension 2005;46:82-6. (Pubitemid 40946495)
22. Dalton K. Early symptoms of pre-eclamptic toxemia. Lancet 1960;23:198-9.
23. Tamimi R, Lagiou P, Vatten L, et al. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 2003;12: 647-50. (Pubitemid 36899846)
24. Zeisler H, Sator M, Joura E. Serum levels of progesterone in patients with preeclampsia. Wien Klin Wochenschr 2000;112: 362-4. (Pubitemid 30256681)
25. Risberg A, Olsson K, Lyrenas S, Sjoquist M. Plasma vasopressin, oxytocin, estradiol and progesterone related to water and sodium excretion in normal pregnancy and gestational hypertension. Acta Obstet Gynecol Scand 2009;88:639-46.